MESAS

A group of world leading clinicians, scientists and methodologists that support organisations to answers health-related questions on clinical, research, decision-making, industry and legal matters

SERVICES

We provide world class consultancy to answer your health-related questions.

MESAS can also serve as a SME partner in EU funding applications. 

FOUNDERS

With a wealth of experience across various medical specialties and research methodologies, our founders are dedicated to delivering the highest quality insights and recommendations.
Take a look at their publications

Dr Marco Solmi

Prof. Marco Solmi

Marco Solmi, MD, psychiatrist, PhD, is Associate Professor and Director of Research, Department of Psychiatry, University of Ottawa, Canada, Medical Director of On Track First Episode Psychosis program and of the Eating Disorders program, The Ottawa Hospital, Scientist, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Charité University Medicine Berlin, visiting academic at University of Southampton, School of psychology and King’s College, IoPPN, Psychosis Department, UK, and affiliate at the METRIC center, Stanford University, USA. He is Chair of ECNP Physical And meNtal Health (PAN-Health) Thematic Working Group (TWG), and member of other European and Canadian psychiatric associations.

He is interested in meta-research and epidemiology, to study prevention/early interventions, psychopharmacology, and physical health in those with mental disorders.

He authored over 550 publications in leading medical journals, and is among Clarivate Highly Cited Researchers in Psychiatry and Psychology since 2021.

Follow on

Dr Veronese Nicola

Prof. Nicola Veronese

Prof. Nicola Veronese, MD, is a certified trained geriatrician, currently working as Associate Professor in Geriatrics and Internal Medicine at the University of Palermo, Italy. He is also Professor at the King Saud University, Saudi Arabia. His research is mainly epidemiological and focused on the most common diseases affecting older people. In particular, his interest areas are osteoarticular, metabolic (including obesity and diabetes) and cardiovascular diseases, as well as nutrition, frailty and sarcopenia.

He is the Editor in Chief of Aging Clinical and Experimental Research and Associate Editor of Age and Ageing (systematic reviews) and involved as member of several scientific journals.

He is the author of more than 700 articles published in national and international scientific journals, and of numerous abstracts accepted by national and international congresses. He is among Clarivate Highly Cited Researchers in Psychiatry and Psychology in 2023 and named as Rising Star in Medicine (20th in the World).

Follow on

Prof. Brendon Stubbs

Dr Brendon Stubbs research focuses on lifestyle interventions, notably physical activity and health.  Since 2019, Dr Stubbs has been ranked as one of the world’s most influential mental health researchers according to Clarivate™. Brendon has published over 800 academic papers, including European and World Psychiatric Association guidelines.  His research has been cited over 65,000 times and informed many national and international policies (e.g. WHO guidelines).  Brendon holds multiple academic positions at leading Universities, including King’s College London.  Dr Stubbs has also held senior (board level) positions at MedTech companies including Chief Scientific and Clinical Safety Officer.  

Brendon’s research is frequently featured in multiple International media outlets such as the New York Times, TIME magazine, Forbes, CNN, Women’s Health, Men’s Health, BBC news, ITV news and Sky News (among others).  Dr Stubbs was the lead scientist for the documentary Mind Games which featured in over 30 countries. 

Dr Stubbs has given over 250 invited International talks to numerous audiences, including business leaders at the World Economic Forum, major sporting events (French Open), large sports brands (e.g. ASICS) and multinational companies (e.g. Amazon).  Dr Stubbs also works as a consultant for many business International businesses that seek to embed evidence-based solutions to demonstrate the impact of their offering. 

Follow on

SCIENTIFIC AND ADVISORY BOARD

To ensure the highest standards of excellence in our services, we’ve assembled a distinguished Scientific and Advisory Board composed of world-renowned experts in the field of human health. Our board members bring a wealth of experience and expertise to our team, guiding our work in evidence synthesis, research design, data analysis, and strategic consulting.

Prof. Pinar Soysal

Pinar Soysal, Professor of Geriatric Medicine at Bezmialem Vakıf University, Istanbul, specializes in geriatric syndromes, dementia, malnutrition, frailty, and polypharmacy. With 300+ publications, she co-leads the European Geriatric Medicine Society's Dementia SIG and recently completed Harvard's Clinical Research Leadership program in 2024.
Pinar Soysal is a certified trained geriatrician, currently working as a Professor in the Department of Geriatric Medicine at Bezmialem Vakıf University, Istanbul, Türkiye. Her research is mainly epidemiological and focused on the most common diseases affecting older people. In particular, her interest areas are common geriatric syndromes, dementia, malnutrition, frailty, and polypharmacy. She is the author of more than 300 articles published in national and international scientific journals and of numerous abstracts accepted by national and international congresses. She has been a co-leader of the Dementia Special Interest Group in the European Geriatric Medicine Society for three years. She also graduated from Harvard Medical School’s Clinical Research Leadership program at the beginning of 2024.
Prof Christopher U Correll

Prof. Christoph U. Correll

Christoph U. Correll, MD, is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He is a global key opinion leader in psychiatry and psychopharmacology.
Christoph U. Correll, MD, is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital in New York. Since 1997, he has been working and conducting research in New York, USA, and since 2017 he is also working in Germany again. Dr. Correll focuses on the identification and treatment of youth and adults with severe mental illness, clinical trials, epidemiology, psychopharmacology, meta-research, and the interface between physical health and mental health. He has authored or co-authored over 900 journal articles that have been cited more than 80.000 times and received over 40 research awards for his work. In July 2024, his H-index was 143 in Google Scholar. Since 2014, the beginning of this metric, he has been listed every year by Clarivate/Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry” (https://hcr.clarivate.com). Additionally, Dr. Correll has been holding numerous Expertscape rankings based on the number of publications and citations in the past 10 years, including being ranked consistently since 2017 as the number one cited world expert in >10 areas, including “central nervous system agents”, “psychotropic drugs“, “schizophrenia”, “schizophrenia spectrum and other psychotic disorders”, “antipsychotics”, “delayed action preparations” and “weight gain”.

Colin Jones

Colin Jones is a Senior Data Scientist specializing in inferential data science, with a focus on opening black boxes and enabling transparent, evidence-based decision-making. He builds predictive models for time series analysis, longitudinal data, and mixed-effects models, with financial, economic, and psychometric applications. Colin is currently completing a PhD in Data Science at Carleton University and holds a Master of Science in Statistics from Western University.
Colin Jones is a Senior Data Scientist and PhD candidate in Data Science at Carleton University, where he conducts research under the supervision of Dr. Dave Campbell. His doctoral work focuses on the detection and treatment of influential outliers in general machine learning models, with an emphasis on improving model transparency and trustworthiness in high-stakes decision-making contexts. Colin specializes in inferential data science, with broad expertise in probabilistic machine learning, time series forecasting, mixed-effects modeling, and applications in finance and economics. His work often addresses the challenge of “opening black boxes” by combining statistical inference with modern predictive modeling, enabling more interpretable and robust outcomes. He has published in peer-reviewed journals and received multiple academic research awards recognizing both the theoretical and applied impact of his work. Colin’s recent projects span large-scale data analysis, the generation and evaluation of synthetic data, and scalable Bayesian methods for modeling complex data environments. He holds a Master of Science in Statistics from Western University, and has developed and deployed models in both academic and industry settings, often working with high-dimensional and large datasets. His passion lies in bridging the gap between statistical rigor and machine learning performance to support evidence-based, transparent decision-making.

REQUEST MESAS SERVICES